Evidence map›Paper›PMID 36493788›Full record

ArticleThe Lancet. Microbe2023

Leveraging an established neighbourhood-level, open access wastewater monitoring network to address public health priorities: a population-based study.

Devin A Bowes, Erin M Driver, Simona Kraberger, Rafaela S Fontenele, LaRinda A Holland, Jillian Wright, Bridger Johnston, Sonja Savic, Melanie Engstrom Newell, Sangeet Adhikari and 18 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet. Microbe, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Wastewater-based epidemiology to assess environmentally influenced disease.Journal of exposure science & environmental epidemiology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 2 institutions in 1 country.

Devin A BowesThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA; School for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ, USA; OneWaterOneHealth, The Arizona State University Foundation, The Biodesign Institute, Arizona State University, Tempe, AZ, USA.
Erin M DriverThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA; School for Sustainable Engineering and the Built Environment, Arizona State University, Tempe, AZ, USA.
Simona KrabergerThe Biodesign Institute Center for Fundamental and Applied Microbiomics, Arizona State University, Tempe, AZ, USA.
Rafaela S FonteneleThe Biodesign Institute Center for Fundamental and Applied Microbiomics, Arizona State University, Tempe, AZ, USA; School of Life Sciences, Arizona State University, Tempe, AZ, USA.
LaRinda A HollandThe Biodesign Institute Center for Fundamental and Applied Microbiomics, Arizona State University, Tempe, AZ, USA.
Jillian WrightThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA; OneWaterOneHealth, The Arizona State University Foundation, The Biodesign Institute, Arizona State University, Tempe, AZ, USA.
Bridger JohnstonThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA.
Sonja SavicThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA.
Melanie Engstrom NewellThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA; School for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ, USA.
Sangeet AdhikariThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA; School for Sustainable Engineering and the Built Environment, Arizona State University, Tempe, AZ, USA.
Rahul KumarThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA.
Hanah GoetzSchool for Engineering of Matter, Transport, and Energy, Arizona State University, Tempe, AZ, USA.
Allison BinsfeldThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA; OneWaterOneHealth, The Arizona State University Foundation, The Biodesign Institute, Arizona State University, Tempe, AZ, USA.
Kaxandra NessiThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA.
Payton WatkinsThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA.
Akhil MahantThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA.
Jacob ZevitzThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA.
Stephanie DeitrickEnterprise GIS & Data Analytics, Information Technology, Tempe, AZ, USA.
Philip BrownMunicipal Utilities, Tempe, AZ, USA.
Richard DaltonMunicipal Utilities, Tempe, AZ, USA.
Chris GarciaMunicipal Utilities, Tempe, AZ, USA.
Rosa InchaustiStrategic Management and Diversity Office, Tempe, AZ, USA.
Wydale HolmesStrategic Management and Diversity Office, Tempe, AZ, USA.
Xiao-Jun TianSchool of Biological and Health Systems Engineering, Arizona State University, Tempe, AZ, USA.
Arvind VarsaniThe Biodesign Institute Center for Fundamental and Applied Microbiomics, Arizona State University, Tempe, AZ, USA; School of Life Sciences, Arizona State University, Tempe, AZ, USA; Center for Evolution and Medicine, Arizona State University, Tempe, AZ, USA.
Efrem S LimThe Biodesign Institute Center for Fundamental and Applied Microbiomics, Arizona State University, Tempe, AZ, USA; School of Life Sciences, Arizona State University, Tempe, AZ, USA.
Matthew ScotchThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA; College of Health Solutions, Arizona State University, Tempe, AZ, USA.
Rolf U HaldenThe Biodesign Institute Center for Environmental Health Engineering, Arizona State University, Tempe, AZ, USA; School for Sustainable Engineering and the Built Environment, Arizona State University, Tempe, AZ, USA; Global Futures Laboratory, Arizona State University, Tempe, AZ, USA; OneWaterOneHealth, The Arizona State University Foundation, The Biodesign Institute, Arizona State University, Tempe, AZ, USA. Electronic address: rolf.halden@asu.edu.
Arizona State University · USCenter for Environmental Health · US

Funding

Bioinformatics Framework for Wastewater-based Surveillance of Infectious DiseasesU01LM013129 · NLM · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI HALDEN, ROLF U, SCOTCH, MATTHEW · 2020 to 2022
$3.3M
NLM NIH HHS U01 LM013129
6 · The paper itself

Abstract

backgroundBefore the COVID-19 pandemic, the US opioid epidemic triggered a collaborative municipal and academic effort in Tempe, Arizona, which resulted in the world's first open access dashboard featuring neighbourhood-level trends informed by wastewater-based epidemiology (WBE). This study aimed to showcase how wastewater monitoring, once established and accepted by a community, could readily be adapted to respond to newly emerging public health priorities.

methodsIn this population-based study in Greater Tempe, Arizona, an existing opioid monitoring WBE network was modified to track SARS-CoV-2 transmission through the analysis of 11 contiguous wastewater catchments. Flow-weighted and time-weighted 24 h composite samples of untreated wastewater were collected at each sampling location within the wastewater collection system for 3 days each week (Tuesday, Thursday, and Saturday) from April 1, 2020, to March 31, 2021 (Area 7 and Tempe St Luke's Hospital were added in July, 2020). Reverse transcription quantitative PCR targeting the E gene of SARS-CoV-2 isolated from the wastewater samples was used to determine the number of genome copies in each catchment. Newly detected clinical cases of COVID-19 by zip code within the City of Tempe, Arizona were reported daily by the Arizona Department of Health Services from May 23, 2020. Maricopa County-level new positive cases, COVID-19-related hospitalisations, deaths, and long-term care facility deaths per day are publicly available and were collected from the Maricopa County Epidemic Curve Dashboard. Viral loads of SARS-CoV-2 (genome copies per day) measured in wastewater from each catchment were aggregated at the zip code level and city level and compared with the clinically reported data using root mean square error to investigate early warning capability of WBE.

findingsBetween April 1, 2020, and March 31, 2021, 1556 wastewater samples were analysed. Most locations showed two waves in viral levels peaking in June, 2020, and December, 2020-January, 2021. An additional wave of viral load was seen in catchments close to Arizona State University (Areas 6 and 7) at the beginning of the fall (autumn) semester in late August, 2020. Additionally, an early infection hotspot was detected in the Town of Guadalupe, Arizona, starting the week of May 4, 2020, that was successfully mitigated through targeted interventions. A shift in early warning potential of WBE was seen, from a leading (mean of 8·5 days [SD 2·1], June, 2020) to a lagging (-2·0 days [1·4], January, 2021) indicator compared with newly reported clinical cases.

interpretationLessons learned from leveraging an existing neighbourhood-level WBE reporting dashboard include: (1) community buy-in is key, (2) public data sharing is effective, and (3) sub-ZIP-code (postal code) data can help to pinpoint populations at risk, track intervention success in real time, and reveal the effect of local clinical testing capacity on WBE's early warning capability. This successful demonstration of transitioning WBE efforts from opioids to COVID-19 encourages an expansion of WBE to tackle newly emerging and re-emerging threats (eg, mpox and polio).

fundingNational Institutes of Health's RADx-rad initiative, National Science Foundation, Virginia G Piper Charitable Trust, J M Kaplan Fund, and The Flinn Foundation.

Indexed as

COVID-19Health PrioritiesWastewaterAccess to InformationAnalgesics, OpioidHumansPandemicsResearch DesignSARS-CoV-2United StatesAnalgesics, OpioidWastewater

Identifiers

PMID36493788
PMCPMC9725778
OpenAlexW4310769239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.